Jean-Jacques Kiladjian/LinkedIn
Apr 18, 2026, 10:58
Jean Jacques Kiladjian: Honored to Join the HST EHA Session at the Taiwan Annual Meeting
Jean Jacques Kiladjian, Head of Clinical Research Department of Inserm, shared a post on LinkedIn:
“Honored to be invited by the Hematology Society of Taiwan and Taiwan Society of Blood and Marrow Transplantation to participate in the joint HST – European Hematology Association (EHA) session during their annual meeting.
Always a great pleasure to be in Taipei and reconnect with colleagues and friends (for my 6th travel in Taiwan!)”
Stay updated with Hemostasis Today.
-
Apr 18, 2026, 10:49Advancing Diagnosis to Improve Lives in Hemophilia – WFH
-
Apr 18, 2026, 10:40Akshat Jain: Improving Treatment and Access for Patients with Bleeding Disorders
-
Apr 18, 2026, 10:24Sonia Wolf: Barts Health Presence at BSH with Multiple Presentations and Awards
-
Apr 18, 2026, 10:22Cathy Harrison: The Central Role of Diagnosis in Bleeding Disorders Management
-
Apr 18, 2026, 10:10Rich Gorman: Understanding Lived Experience in Bleeding Disorders Through Arts-Based Research
-
Apr 18, 2026, 09:45Wolfgang Miesbach: Therapeutic Potential of Protein S Inhibition in Glanzmann Thrombasthenia
-
Apr 18, 2026, 00:44Join leading experts for an evening symposium at the ASPHO Conference – ISTH
-
Apr 17, 2026, 17:41José Antonio García Erce: Hematology in 48 Hours – Advancing Clinical Practice Through Expert Insight
-
Apr 17, 2026, 17:23Alfonso J. Tafur: Endovascular Therapy Improves Post-Thrombotic Syndrome Outcomes at 6 Months